GlassScriptPhysician profile
Joseph B Eisenach
NPI 1669475679
$378.58
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $31.14 · 2020: $33.19 · 2021: $115 · 2022: $69.96 · 2023: $109 · 2024: $20.43.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $130.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $129.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $146.62 | 2021-2023 | Stelara |
| Abbvie INC. | $69.16 | 2020-2023 | |
| Regeneron Healthcare Solutions, INC. | $51.28 | 2022-2023 | Dupixent |
| Nestle Healthcare Nutrition INC. | $23.57 | 2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $21.07 | 2023 | Trulance, Uceris |
| Celgene Corporation | $20.43 | 2024 | Zeposia |
| Ethicon US, LLC | $19.96 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $15.31 | 2020 | |
| Pfizer INC. | $11.18 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Eisenach listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.